d.oyelaran
Submits third-party assay reports on material purchased directly. Based in Valencia.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
99.33%
n=8
Suppliers covered
6
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043086 | Semaglutide | KP | KP-2511-J5553 | PeptideMeter | 2026-Q2 | 99.85 | 7.54 | 90.5 | Buyer-sourced | 0 | PASS |
| AX-2026-042714 | GHK-Cu | ERP | ERP-2601-F9816 | Kestrel | 2026-Q2 | 98.93 | 4.31 | 106.7 | Buyer-sourced | 2 | MARGINAL |
| AX-2026-043586 | SS-31 (Elamipretide) | SIG | SIG-2512-6369 | Janoshik | 2026-Q1 | 99.31 | 6.75 | 103.8 | Buyer-sourced | 0 | PASS |
| AX-2024-005402 | Melanotan II | PPG | PPG-2408-L8298 | Nordanalyt | 2024-Q4 | 99.93 | 4.60 | 105.2 | Buyer-sourced | 0 | PASS |
| AX-2024-005015 | Semaglutide | KP | KP-2405-C4939 | Medutest | 2024-Q3 | 98.02 | 5.08 | 88.9 | Buyer-sourced | 1 | MARGINAL |
| AX-2024-004509 | Retatrutide | HYB | HYB-2407-W6594 | Medutest | 2024-Q3 | 98.23 | 5.38 | — | Buyer-sourced | 0 | FAIL |
| AX-2024-004227 | Liraglutide | WWB | WWB-2406-R3462 | Medutest | 2024-Q3 | 99.35 | 2.46 | 93.3 | Buyer-sourced | 0 | PASS |
| AX-2024-004868 | Ipamorelin | ERP | ERP-2406-F9295 | Nordanalyt | 2024-Q3 | 99.41 | 3.97 | — | Buyer-sourced | 0 | PASS |